Selective alterations of the antibody response to HIV-1

被引:0
|
作者
Laure Juompan
Patrick Lambin
Moncef Zouau
机构
[1] Institut Pasteur,Département d’Immunologie
[2] Unité d’Immunologie Transfusionelle,undefined
来源
关键词
Superantigen; gpl20; HIV; B-cell; human antibodies; immunoglobulin variable genes; isotypes; mucosal antibodies;
D O I
暂无
中图分类号
学科分类号
摘要
HIV infection leads to progressive alterations of humoral immune functions, including B-cell hyperplasia, hypergammaglobulinemia, elevated autoantibody titers, a poor response to neoantigens and mitogens, polyclonal B-cell activation, monoclonal gammopathies, and a significant deterioration of the antigen-specific humoral response. There is also an important isotypic imbalance of the antibody (Ab) response in the systemic compartment and a profound modification of mucosal immune functions. These abnormalities may contribute to disease progression and development of opportunistic infections, despite the presence of serum-neutralizing anti-HIV Abs. Equally important are the abnormal selection mechanisms of the Ab repertoire that seem to be responsible for B-cell clonal deletions. The VH3 gene family, which encodes for approx 50% of immunoglobulins expressed by peripheral B-cells from normal adults, is underrepresented in human monoclonal antibodies to HIV-1 and in the peripheral B-cells of AIDS patients. These abnormalities, together with features of germinal center alteration, could be responsible for the clonal elimination of a subset of B-cells, and could contribute to HIV pathogenesis.
引用
收藏
页码:139 / 150
页数:11
相关论文
共 50 条
  • [21] Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS
    Scarlatti, G
    Leitner, T
    Hodara, V
    Jansson, M
    Karlsson, A
    Wahlberg, J
    Rossi, P
    Uhlen, M
    Fenyo, EM
    Albert, J
    IMMUNOLOGY LETTERS, 1996, 51 (1-2) : 23 - 28
  • [22] Characterization of the antibody response elicited by HIV-1 Env glycomutants in rabbits
    Reynard, F.
    Willkomm, N.
    Fatmi, A.
    Vallon-Eberhard, A.
    Verrier, B.
    Bedin, F.
    VACCINE, 2007, 25 (03) : 535 - 546
  • [23] HIV-1 Superinfection in Women Broadens and Strengthens the Neutralizing Antibody Response
    Cortez, Valerie
    Odem-Davis, Katherine
    McClelland, R. Scott
    Jaoko, Walter
    Overbaugh, Julie
    PLOS PATHOGENS, 2012, 8 (03)
  • [24] Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
    Mikell, Iliyana
    Sather, D. Noah
    Kalams, Spyros A.
    Altfeld, Marcus
    Alter, Galit
    Stamatatos, Leonidas
    PLOS PATHOGENS, 2011, 7 (01)
  • [25] A plant virus HIV-1 chimera stimulates antibody that neutralizes HIV-1
    McLain, L
    Durrani, Z
    Dimmock, NJ
    Wisniewski, LA
    Porta, C
    Lomonossoff, GP
    VACCINES 96 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES, 1996, : 311 - 316
  • [26] RETROCELL HIV-1 PASSIVE HEMAGGLUTINATION ASSAY FOR HIV-1 ANTIBODY SCREENING
    SCHEFFEL, JW
    WIESNER, D
    KAPSALIS, A
    TRAYLOR, D
    SUAREZ, A
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 (05): : 540 - 545
  • [27] Perinatal HIV-1 infection in a child without HIV-1 antibody formation
    Moreno-Pérez, D
    Saiz, AG
    Martín, FJG
    Ortiz, AJ
    MEDICINA CLINICA, 2005, 125 (06): : 237 - 238
  • [28] RECOMBINANT ANTIBODY FRAGMENTS TO HIV-1
    WATKINS, BA
    VERONESE, F
    DAVIS, AE
    REITZ, MS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S73 - S73
  • [29] DETECTION OF ANTIBODY TO HIV-1 IN URINE
    DESAI, S
    BATES, H
    MICHALSKI, FJ
    LANCET, 1991, 337 (8734): : 183 - 184
  • [30] HIV-1 antibody - Debris or virion?
    Parren, PWHI
    Burton, DR
    Sattentau, QJ
    NATURE MEDICINE, 1997, 3 (04) : 366 - 367